Integrated Drug Reviews at the US Food and Drug Administration - Reply

TY - JOUR

T1 - Integrated Drug Reviews at the US Food and Drug Administration - Reply

AU - Doshi, Peter

AU - Morten, Christopher J.

AU - Herder, Matthew

N1 - Funding Information: Conflict of Interest Disclosures: Dr Doshi reported grants from the Laura and John Arnold Foundation, the Cochrane Methods Innovation Fund via Health Reviews Ltd, UK National Institute for Health Research, and the American Association of Colleges of Pharmacy; and is an associate editor of the British Medical Journal and an unpaid member of the Innovation in Medical Evidence Development and Surveillance steering committee at the Reagan-Udall Foundation for the US Food and Drug Administration. Dr Morten reported receiving personal fees from Yale University’s Collaboration for Research Integrity and Transparency, which has received grant funds from Arnold Ventures. Dr Herder reported grants from the Canadian Institutes of Health Research and personal fees from the Patented Medicine Prices Review Board.

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85089038110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089038110&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2020.1978

DO - 10.1001/jamainternmed.2020.1978

M3 - Letter

C2 - 32730622

AN - SCOPUS:85089038110

SN - 2168-6106

VL - 180

SP - 1260

EP - 1261

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

IS - 9

ER -